Kelfred Holdings Limited (1134.HK)

Healthcare | Medical Instruments Supplies

Income Statement (Quarterly)	2026-04-08	2025-06-30	2025-03-31	2024-12-31
Revenue	242,524,000	242,524,000	121,262,000	128,084,499
Cost of Revenue	211,313,000	211,313,000	105,656,500	114,646,000
Gross Profit	31,211,000	31,211,000	15,605,500	13,438,499
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	34,808,000	34,808,000	17,404,000	20,512,000
Operating Expenses	33,082,000	33,082,000	16,541,000	17,347,499
Operating Income	-1,871,000	-1,871,000	-935,500	-3,909,000
Interest Expense	0	1,543,000	0	0
Income Before Tax	-3,420,000	-3,420,000	-1,710,000	-4,478,000
Income Tax Expense	1,297,000	1,297,000	648,500	213,000
Net Income	-4,717,000	-4,717,000	-2,358,500	-4,691,000
Per Share
EPS	-0.01	-0.01	0.00	-0.01
EPS Diluted	0.00	0.00	0.00	0.00

Income Statement (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	453,581,000	393,284,000	465,430,000	434,732,000	354,183,000
Cost of Revenue	408,916,000	336,305,000	389,413,000	366,290,000	294,043,000
Gross Profit	44,665,000	56,979,000	76,017,000	68,442,000	60,140,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	76,940,000	77,250,000	78,245,000	74,686,000	69,199,000
Operating Expenses	64,122,000	53,148,000	68,989,000	66,822,000	62,649,000
Operating Income	-19,457,000	3,831,000	11,396,000	-1,105,000	-2,509,000
Interest Expense	1,980,000	1,678,000	734,000	502,000	839,000
Income Before Tax	-21,437,000	2,178,000	10,681,000	-1,587,000	-12,190,000
Income Tax Expense	195,000	790,000	1,498,000	553,000	1,331,000
Net Income	-21,632,000	1,388,000	9,183,000	-2,140,000	-13,402,000
Per Share
EPS	-0.04	0.00	0.02	0.00	-0.03
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance Sheet (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	27,813,000	20,334,000	46,403,000	36,930,000
Short Term Investments	0	0	0	0
Net Receivables	116,775,000	112,493,000	100,574,000	0
Inventory	85,807,000	77,933,000	71,183,000	80,737,000
Total Current Assets	239,178,000	212,668,000	221,846,000	232,353,000
Property Plant Equipment	42,430,000	50,829,000	29,936,000	35,779,000
Goodwill and Intangibles	0	0	0	0
Total Assets	282,928,000	264,004,000	251,896,000	268,132,000
Liabilities
Account Payables	91,173,000	44,175,000	39,983,000	52,665,000
Short Term Debt	3,376,000	2,747,000	1,223,000	2,551,000
Total Current Liabilities	117,309,000	68,143,000	64,341,000	80,149,000
Long Term Debt	9,185,000	12,472,000	785,000	1,453,000
Total Liabilities	126,494,000	80,813,000	65,324,000	81,800,000
Shareholders Equity
Retained Earnings	-154,000	21,843,000	20,893,000	0
Total Shareholders Equity	156,434,000	183,191,000	186,572,000	186,332,000

Balance Sheet (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets
Cash and Cash Equivalents	27,813,000	20,334,000	46,403,000	36,930,000	76,384,000
Short Term Investments	0	0	0	0	0
Net Receivables	116,775,000	112,493,000	100,574,000	0	0
Inventory	85,807,000	77,933,000	71,183,000	80,737,000	59,732,000
Total Current Assets	239,178,000	212,668,000	221,846,000	232,353,000	245,123,000
Property Plant Equipment	42,430,000	50,829,000	29,936,000	35,779,000	42,051,000
Goodwill and Intangibles	0	0	0	0	0
Total Assets	282,928,000	264,004,000	251,896,000	268,132,000	287,174,000
Liabilities
Account Payables	91,173,000	44,175,000	39,983,000	52,665,000	66,665,000
Short Term Debt	3,376,000	2,747,000	1,223,000	2,551,000	10,936,000
Total Current Liabilities	117,309,000	68,143,000	64,341,000	80,149,000	99,197,000
Long Term Debt	9,185,000	12,472,000	785,000	1,453,000	2,556,000
Total Liabilities	126,494,000	80,813,000	65,324,000	81,800,000	101,951,000
Shareholders Equity
Retained Earnings	-154,000	21,843,000	20,893,000	0	0
Total Shareholders Equity	156,434,000	183,191,000	186,572,000	186,332,000	185,223,000

Cash Flow Statement (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	-21,437,000	1,388,000	10,681,000	-2,140,000
Depreciation & Amortization	12,162,000	10,388,000	9,686,000	14,184,000
Stock Based Compensation	0	0	0	0
Change in Working Capital	27,048,000	-20,150,000	-1,045,000	-39,186,000
Operating Cash Flow	17,493,000	-4,635,000	19,278,000	-21,872,000
Investing Activities
Capital Expenditure	-4,950,000	-15,688,000	-4,688,000	-5,137,000
Investments	-4,950,000	-15,688,000	-4,688,000	-5,137,000
Investing Cash Flow	-4,799,000	-16,615,000	-5,211,000	-5,728,000
Financing Activities
Debt Repayment	-3,047,000	0	-2,913,000	-8,000,000
Common Stock Issued/Repurchased	0	0	0	0
Dividends Paid	0	0	0	0
Financing Cash Flow	-5,027,000	-4,247,000	-3,647,000	-11,742,000
Summary
Free Cash Flow	12,543,000	-20,323,000	14,590,000	-27,009,000
Net Change in Cash	7,479,000	-26,069,000	9,473,000	-39,454,000

Cash Flow Statement (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Operating Activities
Net Income	-21,437,000	1,388,000	10,681,000	-2,140,000	-13,402,000
Depreciation & Amortization	12,162,000	10,388,000	9,686,000	14,184,000	13,202,000
Stock Based Compensation	0	0	0	0	0
Change in Working Capital	27,048,000	-20,150,000	-1,045,000	-39,186,000	11,822,000
Operating Cash Flow	17,493,000	-4,635,000	19,278,000	-21,872,000	22,014,000
Investing Activities
Capital Expenditure	-4,950,000	-15,688,000	-4,688,000	-5,137,000	-5,334,000
Investments	-4,950,000	-15,688,000	-4,688,000	-5,137,000	-5,334,000
Investing Cash Flow	-4,799,000	-16,615,000	-5,211,000	-5,728,000	-5,188,000
Financing Activities
Debt Repayment	-3,047,000	0	-2,913,000	-8,000,000	-23,822,000
Common Stock Issued/Repurchased	0	0	0	0	0
Dividends Paid	0	0	0	0	-11,000,000
Financing Cash Flow	-5,027,000	-4,247,000	-3,647,000	-11,742,000	-23,903,000
Summary
Free Cash Flow	12,543,000	-20,323,000	14,590,000	-27,009,000	16,680,000
Net Change in Cash	7,479,000	-26,069,000	9,473,000	-39,454,000	-7,329,000